BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendonça DVC, Lage DP, Calixto SL, Ottoni FM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Schneider MS, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Parasitol Res 2018;117:391-403. [PMID: 29248978 DOI: 10.1007/s00436-017-5713-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Brioschi MBC, Coser EM, Coelho AC, Gadelha FR, Miguel DC. Models for cytotoxicity screening of antileishmanial drugs: what has been done so far? Int J Antimicrob Agents 2022;:106612. [PMID: 35691601 DOI: 10.1016/j.ijantimicag.2022.106612] [Reference Citation Analysis]
2 Rani R, Narsiman B, Varma RS, Kumar R. Gum-based nanocapsules comprising naphthoquinones enhance the apoptotic and trypanocidal activity against Trypanosoma evansi. Eur J Pharm Sci 2022;171:106118. [PMID: 35007713 DOI: 10.1016/j.ejps.2022.106118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dias-Lopes G, Zabala-Peñafiel A, de Albuquerque-Melo BC, Souza-Silva F, Menaguali do Canto L, Cysne-Finkelstein L, Alves CR. Axenic amastigotes of Leishmania species as a suitable model for in vitro studies. Acta Trop 2021;220:105956. [PMID: 33979642 DOI: 10.1016/j.actatropica.2021.105956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Peixoto JF, Oliveira ADS, Monteiro PQ, Gonçalves-Oliveira LF, Andrade-Neto VV, Ferreira VF, Souza-Silva F, Alves CR. In Silico Insights into the Mechanism of Action of Epoxy-α-Lapachone and Epoxymethyl-Lawsone in Leishmania spp. Molecules 2021;26:3537. [PMID: 34200517 DOI: 10.3390/molecules26123537] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Silva DKC, Teixeira JS, Moreira DRM, da Silva TF, Barreiro EJL, de Freitas HF, Pita SSDR, Teles ALB, Guimarães ET, Soares MBP. In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis. Front Pharmacol 2020;11:590544. [PMID: 33390966 DOI: 10.3389/fphar.2020.590544] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 2021;120:321-35. [PMID: 33191446 DOI: 10.1007/s00436-020-06971-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rodrigues RRL, Nunes TAL, de Araújo AR, Marinho Filho JDB, da Silva MV, Carvalho FAA, Pessoa ODL, Freitas HPS, Rodrigues KADF, Araújo AJ. Antileishmanial activity of cordiaquinone E towards Leishmania (Leishmania) amazonensis. Int Immunopharmacol 2021;90:107124. [PMID: 33168414 DOI: 10.1016/j.intimp.2020.107124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 da Câmara Rocha J, da Franca Rodrigues KA, do Nascimento Néris PL, da Silva LV, Almeida FS, Lima VS, Peixoto RF, da Câmara Rocha J, de Azevedo FLAA, Veras RC, de Medeiros IA, da Silva WAV, Lima-Junior CG, de Almeida Vasconcellos MLA, do Amaral IPG, de Oliveira MR, de Souza Lima Keesen T. Biological activity of Morita-Baylis-Hillman adduct homodimers in L. infantum and L. amazonensis: anti-Leishmania activity and cytotoxicity. Parasitol Res 2019;118:3067-76. [PMID: 31392413 DOI: 10.1007/s00436-019-06403-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Sousa JKT, Antinarelli LMR, Mendonça DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Chávez-Fumagalli MA, Brandão GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitol Int 2019;73:101966. [PMID: 31362122 DOI: 10.1016/j.parint.2019.101966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
10 Vale DL, Dias DS, Machado AS, Ribeiro PAF, Lage DP, Costa LE, Steiner BT, Tavares GSV, Ramos FF, Martínez-Rodrigo A, Chávez-Fumagalli MA, Caligiorne RB, de Magalhães-Soares DF, Silveira JAG, Machado-de-Ávila RA, Teixeira AL, Coelho EAF. Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls. Diagn Microbiol Infect Dis 2019;95:134-43. [PMID: 31155395 DOI: 10.1016/j.diagmicrobio.2019.04.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
11 Oyama J, Lera-Nonose DSSL, Ramos-Milaré ÁCFH, Padilha Ferreira FB, de Freitas CF, Caetano W, Hioka N, Silveira TGV, Lonardoni MVC. Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy. Acta Trop 2019;192:11-21. [PMID: 30659806 DOI: 10.1016/j.actatropica.2019.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Exp Parasitol 2019;199:30-7. [PMID: 30817917 DOI: 10.1016/j.exppara.2019.02.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
13 Mendonça DV, Tavares GS, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PA, Ottoni FM, Antinarelli LM, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Chávez-fumagalli MA, Roatt BM, Menezes-souza D, Barichello JM, Alves RJ, Coelho EA. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection. Biomedicine & Pharmacotherapy 2019;109:779-87. [DOI: 10.1016/j.biopha.2018.10.143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
14 Calixto SL, Glanzmann N, Xavier Silveira MM, da Trindade Granato J, Gorza Scopel KK, Torres de Aguiar T, DaMatta RA, Macedo GC, da Silva AD, Coimbra ES. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp. Chem Biol Interact 2018;293:141-51. [PMID: 30098941 DOI: 10.1016/j.cbi.2018.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]